Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial
Authors
Keywords
Paclitaxel, Gastric cancer, Intraperitoneal administration, Peritoneal carcinomatosis
Journal
Gastric Cancer
Volume 20, Issue 1, Pages 190-199
Publisher
Springer Nature
Online
2016-02-15
DOI
10.1007/s10120-016-0598-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer
- (2015) Maria Di Vita et al. ANTI-CANCER DRUGS
- Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)
- (2015) Tomohiro Nishina et al. Gastric Cancer
- Staging Laparoscopy for Patients with cM0, Type 4, and Large Type 3 Gastric Cancer
- (2015) Yuichiro Miki et al. WORLD JOURNAL OF SURGERY
- A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106)
- (2014) Keisuke Kurimoto et al. Gastric Cancer
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis
- (2014) Gaya Spolverato et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial
- (2014) Akira Tsuburaya et al. LANCET ONCOLOGY
- Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale
- (2013) F. Roviello et al. EJSO
- Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210)
- (2013) Yoshiaki Iwasaki et al. JOURNAL OF SURGICAL ONCOLOGY
- Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2
- (2011) Isao Miyashiro et al. Gastric Cancer
- Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 Lymph node dissection
- (2011) Motohiro Imano et al. JOURNAL OF SURGICAL ONCOLOGY
- A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial)
- (2010) Y. Kodera et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis
- (2009) H. Ishigami et al. ANNALS OF ONCOLOGY
- Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma
- (2009) Masafumi Kuramoto et al. ANNALS OF SURGERY
- A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study)
- (2009) Y. Kodera et al. EJSO
- Phase I Pharmacokinetic Study of Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Advanced Gastric Cancer
- (2009) Hironori Ishigami et al. ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search